EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sensitizing methicillin-resistant Staphylococcus aureus (MRSA) to cefuroxime: the synergic effect of bicarbonate and the wall teichoic acid inhibitor ticlopidine

Selvi C Ersoy iD, Richard A Proctor, Warren E Rose iD, Wessam Abdelhady, Sook-Ha Fan iD, Sabrina L Madrigal, Ahmed M Elsayed, Henry F Chambers, Rita G Sobral iD, Arnold S Bayer

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.01627-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Selvi C Ersoy und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Lundquist Institute for Biomedical Innovations at Harbor-UCLA Medical Center, Torrance, California, USA. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Endocarditis, Bacterial, Staphylococcal Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methicillin-resistant Staphylococcus aureus (MRSA) strains are a major challenge for clinicians due, in part, to their resistance to most β-lactams, the first-line treatment for methicillin-susceptible S. aureus . A phenotype termed “NaHCO 3 -responsiveness” has been identified, wherein many clinical MRSA isolates are rendered susceptible to standard-of-care β-lactams in the presence of physiologically relevant concentrations of NaHCO 3 , in vitro and ex vivo ; moreover, such “NaHCO 3 -responsive” isolates can be effectively cleared by β-lactams from target tissues in experimental infective endocarditis (IE). One mechanistic impact of NaHCO 3 exposure on NaHCO 3 -responsive MRSA is to repress WTA synthesis. This NaHCO 3 effect mimics the phenotype of tarO -deficient MRSA, including sensitization to the PBP2-targeting β-lactam, cefuroxime (CFX). Herein, we further investigated the impacts of NaHCO 3 exposure on CFX susceptibility in the presence and absence of a WTA synthesis inhibitor, ticlopidine (TCP), in a collection of clinical MRSA isolates from skin and soft tissue infections (SSTI) and bloodstream infections (BSI). NaHCO 3 and/or TCP enhanced susceptibility to CFX in vitro , by both minimum inhibitor concentration (MIC) and time-kill assays, as well as in an ex vivo simulated endocarditis vegetations (SEV) model, in NaHCO 3 -responsive MRSA. Furthermore, in experimental IE (presumably in the presence of endogenous NaHCO 3 ), pre-exposure to TCP prior to infection sensitized the NaHCO 3 -responsive MRSA strain (but not the non-responsive strain) to enhanced clearances by CFX in target tissues. These data support the notion that NaHCO 3 is acting similarly to WTA synthesis inhibitors, and that such inhibitors have potential translational applications in the treatment of certain MRSA strains in conjunction with specific β-lactam agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusEndocarditis, BacterialStaphylococcal InfectionsHumansAnti-Bacterial AgentsCefuroximeBicarbonatesStaphylococcus aureusbeta-LactamsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

NaHCO3-responsiveexperimental infective endocarditis (IE)methicillin-resistant Staphylococcus aureus (MRSA)penicillin-binding proteins (PBPs)wall teichoic acid (WTA) synthesisβ-lactams

Substanzen

Anti-Bacterial AgentsCefuroximeBicarbonatesbeta-Lactams

Autor:innen und Institutionen

  • The Lundquist Institute for Biomedical Innovations at Harbor-UCLA Medical Center, Torrance, California, USA.
  • Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • California State University-Los Angeles, Los Angeles, California, USA.
  • University of California-San Francisco School of Medicine, San Francisco, California, USA.

ORCID-Profile: Selvi C Ersoy, Warren E Rose, Sook-Ha Fan, Rita G Sobral

Förderung

  • NIAID NIH HHS
  • HHS | National Institutes of Health

Zitieren

APA

Ersoy, S. C., Proctor, R. A., Rose, W. E., Abdelhady, W., Fan, S. H., Madrigal, S. L., Elsayed, A. M., Chambers, H. F., Sobral, R. G., & Bayer, A. S. (2024). Sensitizing methicillin-resistant Staphylococcus aureus (MRSA) to cefuroxime: the synergic effect of bicarbonate and the wall teichoic acid inhibitor ticlopidine. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01627-23

Vancouver

Ersoy SC, Proctor RA, Rose WE, Abdelhady W, Fan SH, Madrigal SL, et al. Sensitizing methicillin-resistant Staphylococcus aureus (MRSA) to cefuroxime: the synergic effect of bicarbonate and the wall teichoic acid inhibitor ticlopidine. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.01627-23

BibTeX
@article{Ersoy2024,
  author = {Ersoy, Selvi C and Proctor, Richard A and Rose, Warren E and Abdelhady, Wessam and Fan, Sook-Ha and Madrigal, Sabrina L and Elsayed, Ahmed M and Chambers, Henry F and Sobral, Rita G and Bayer, Arnold S},
  title = {Sensitizing methicillin-resistant Staphylococcus aureus (MRSA) to cefuroxime: the synergic effect of bicarbonate and the wall teichoic acid inhibitor ticlopidine},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.01627-23}
}
Kostenlos starten →